Cellectar Biosciences share price logo

Cellectar Biosciences

NASDAQ: CLRB

$1.80

-0.28

(-13.25%)

as on

Cellectar Biosciences Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's High

    $1.80
    $2.07

    15.00%

    Upside

    downward going graph
  • 52 Week's High

    $1.80
    $6.52

    262.22%

    Upside

    downward going graph

Cellectar Biosciences share price movements today

Previous Close
$2.08
Open
$2.07
Volume
580.7K
Market Cap
$19.6M
Day's Low - High
$1.80 - $2.07
52 Week Low - High
$1.80 - $6.52

Cellectar Biosciences Historical Returns

1 Month Return
-29.13 %
3 Month Return
-28.57 %
1 Year Return
-67.39 %
3 Year Return
-97.58 %
5 Year Return
-99.39 %

Cellectar Biosciences Stock Fundamentals & Key Indicators

Check Cellectar Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.6M

EPS (TTM)

-4.56

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.46

Industry PE ratio

-2.65

PEG Ratio

-0.0026317525438127004

EBITDA

-22.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-165.71%

Cellectar Biosciences Stock Valuation

Track how Cellectar Biosciences P/E has moved over time to understand its valuation trends.

Cellectar Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-1.52x)

December 31, 2021

Industry (-2.65x)

December 31, 2025

Today (-0.35x)

December 31, 2025

Highest (-0.25x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.35x

Cellectar Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cellectar Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$19.6M-99.39%-0.460.00%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Cellectar Biosciences Stock including INR - Dollar returns

The Cellectar Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cellectar Biosciences investment value today

Current value as on today

₹35,197

Returns

-₹64,803

(-64.8%)

Returns from Cellectar Biosciences Stock

-₹67,391 (-67.39%)

Dollar Impact

₹2,588 (+2.59%)

Analyst Recommendation on Cellectar Biosciences Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Cellectar Biosciences. Average target price of $11.5

Cellectar Biosciences Share Price Target

Get share price movements and forecasts by analysts on Cellectar Biosciences.

What analysts predicted

84.35%UPSIDE

Target Price

$11.5

Current Price

$1.8

Analyzed by

1 Analysts

High

$10

Target

$11.50

Low

$10

Cellectar Biosciences target price $11.5, a slight upside of 84.35% compared to current price of $1.8. According to 1 analysts rating.

Indian Investors' Interest in Cellectar Biosciences Stock

Search interest for Cellectar Biosciences Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-72% versus previous 30 day period

Cellectar Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
-
Operating Income
-12
-13
-13
-12
-6
-6
-4
-5
-5
-7
EBITDA
-26
0
-14
-2
-6
-5
-4
-5
-5
-6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-26
0
-14
-2
-6
-5
-4
-5
-5
-6
Income Tax Expense
-
-
-
0
-
-
-
-
-
-
Net Income
-26
0
-14
-2
-6
-5
-4
-5
-5
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cellectar Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-1
0
0
-
-
-
-
-
0
Operating Income
-13
-13
-14
-15
-24
-28
-38
-51
-22
EBITDA
-12
-13
-13
-14
-23
-31
-42
-44
-21
Interest Expense
0
0
-
-
-
-
-
-
-
Depreciation
1
0
0
0
0
0
0
0
0
Income Before Tax
-13
-13
-14
-15
-24
-31
-42
-44
-21
Income Tax Expense
-
-
-
-
-
0
0
0
-
Net Income
-13
-13
-14
-15
-24
-31
-42
-44
-21
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cellectar Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-26
0
-14
-2
-6
-5
-4
-5
-5
-6
Operating Cash Flow
-13
-14
-9
-10
-9
-5
-4
-4
-4
-6
Investing Cash Flow
0
0
-
0
-
-
-
0
0
-
Financing Cash Flow
43
0
17
-
-
2
5
4
-
31
Change in Cash
30
-14
8
-10
-9
-2
1
0
-4
25

Cellectar Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-13
-14
-15
-24
-28
-42
-44
-21
Operating Cash Flow
-11
-11
-11
-13
-22
-25
-32
-47
-23
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
9
15
9
60
1
9
22
61
13
Change in Cash
-1
3
-2
46
-21
-15
-10
13
-10

Mutual Funds that own Cellectar Biosciences Stock

Check out the Mutual Funds with significant holdings in Cellectar Biosciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.866304%
81884
Fidelity Concord Street Trust
0.297954%
28163

Global Institutional Holdings in Cellectar Biosciences

Funds
Holdings
Vanguard
3.39%
VANGUARD INDEX FUNDS
0.87%
Fidelity Concord Street Trust
0.3%

Insights on Cellectar Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 200.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 779.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CLRB stock has moved down by -24.4%

About Cellectar Biosciences

Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemotherapeutic program, which is in preclinical stages with the aim of treating solid tumors. The firm also participates in collaborative PDC development initiatives with partners such as Avicenna Oncology GMBH for the CLR 2000 Series, Orano Med for the CLR 12120 Series, as well as IntoCell Inc. and LegoChemBio. Established in 2002, Cellectar Biosciences maintains its corporate headquarters in Florham Park, New Jersey.
OrganisationCellectar Biosciences
Headquarters100 Campus Drive, Florham Park, NJ, 07932, US
IndustryBiotechnology
CEOJames V. Caruso
E-voting on sharesClick here to vote

Key Management of Cellectar Biosciences

Name

Title

Mr. Jarrod Longcor

Chief Operating Officer

Mr. James V. Caruso

President, CEO & Director

Mr. Chad J. Kolean CPA

VP, CFO & Secretary

FAQs

What is Cellectar Biosciences share price today?

Cellectar Biosciences share price today is $1.80 as on at the close of the market. Cellectar Biosciences share today touched a day high of $2.07 and a low of $1.80.

What is the 52 week high and 52 week low for Cellectar Biosciences share?

Cellectar Biosciences share touched a 52 week high of $6.52 on and a 52 week low of $1.80 on . Cellectar Biosciences stock price today i.e. is closed at $1.80,which is 72.39% down from its 52 week high and 0.00% up from its 52 week low.

What is Cellectar Biosciences's market capitalisation today?

Cellectar Biosciences market capitalisation is $0.00T as on .

How to invest in Cellectar Biosciences Stock (CLRB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cellectar Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cellectar Biosciences Shares that will get you 0.8333 shares as per Cellectar Biosciences share price of $1.80 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Cellectar Biosciences Stock (CLRB) from India?

Indian investors can start investing in Cellectar Biosciences (CLRB) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Cellectar Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Cellectar Biosciences share’s latest price of $1.80 as on September 26, 2026 at 8:45 am IST, you will get 5.5556 shares of Cellectar Biosciences. Learn more about fractional shares .

What are the returns that Cellectar Biosciences has given to Indian investors in the last 5 years?

Cellectar Biosciences stock has given -99.39% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?